Sarepta Therapeutics
SRPT
#1466
Rank
โ‚น1.017 T
Marketcap
โ‚น10,672
Share price
0.09%
Change (1 day)
8.82%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Sarepta Therapeutics (SRPT) - Total debt

Total debt on the balance sheet as of June 2024 : โ‚น114.92 B

According to Sarepta Therapeutics 's latest financial reports the company's total debt is โ‚น114.92 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Sarepta Therapeutics - Total debt on balance sheet (from 2007 to 2024)

Total debt by year

Year Total debt Change
2023-12-31โ‚น116.28 B-13.12%
2022-12-31โ‚น133.83 B55.7%
2021-12-31โ‚น85.95 B9.74%
2020-12-31โ‚น78.33 B50.83%
2019-12-31โ‚น51.93 B77.53%
2018-12-31โ‚น29.25 B6.29%
2017-12-31โ‚น27.52 B2407.85%
2016-12-31โ‚น1.09 B-29.41%
2015-12-31โ‚น1.55 B288.22%
2014-12-31โ‚น0.40 B288.49%
2013-12-31โ‚น0.10 B7.14%
2012-12-31โ‚น96.21 M-1.26%
2011-12-31โ‚น97.44 M13.03%
2010-12-31โ‚น86.21 M-7.51%
2009-12-31โ‚น93.2 M-27.61%
2008-12-31โ‚น0.12 B52.45%
2007-12-31โ‚น84.45 M

Total debt for similar companies or competitors

Company Total debt differencediff. Country
โ‚น1.958 T 1,604.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น19.56 B-82.97%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.70 B-99.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น68.93 B-40.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น109.37 B-4.83%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น33.18 B-71.13%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น102.13 B-11.13%๐Ÿ‡บ๐Ÿ‡ธ USA